We are live on
!
Find out more
SC
Settian Capital Portfolio holdings
AUM
$156M
1-Year Est. Return
14.17%
This Fund
S&P 500
This Quarter
Est. Return
+8%
1 Year Est. Return
+14.17%
3 Year Est. Return
+62.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$120M
AUM Growth
+$5.58M
(+4.9%)
Cap. Flow
-$1.44M
Cap. Flow
% of AUM
-1.2%
Top 10 Holdings %
Top 10 Hldgs %
59.89%
Holding
36
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$1.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.02% |
| 2 | Energy | 22.33% |
| 3 | Financials | 21.53% |
| 4 | Healthcare | 10.26% |
| 5 | Materials | 7.57% |
Similar funds
BF
RWC
ACL
FLP
RB
CP
CWM
JAA
Settian Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Settian Capital held 36 positions worth $120M, up 4.9% from $114M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.8%. Settian Capital opened no new positions and exited 1, leaving the 36-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Energy and Financials.
- Settian Capital fully exited West Pharmaceutical in Q1 2023, selling an estimated $1.44M.
- Settian Capital's ten largest holdings make up 60% of its $120M portfolio in Q1 2023.
- Settian Capital opened 0 new positions and closed 1 in Q1 2023.
- Settian Capital's portfolio value rose 4.9% quarter-over-quarter to $120M.
Based on Settian Capital's 13F filing for Q1 2023, filed 10 May 2023.